McHugh Thomas S
Chief Financial Officer
1 company
Insider Signal Score
73
StrongTrades Analyzed
6
12M Win Rate
83.3%
Avg 3M Return
+12.4%
Avg 12M Return
+52.8%
McHugh Thomas S is a Chief Financial Officer at AVADEL PHARMACEUTICALS PLC. Recent SEC Form 4 filings include 9 buys and 0 sells.
Holdings by Company
AVDLMar 5, 2025
Current Shares100.4K
Est. Value-
Net Activity+87.8K
Bought: 87.8KSold: 0
Transaction History
Showing 9 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 2,300 | $10.44 | $24,018.67 | +2.7% | -19.2% | +105.6% | |
| Dec 11, 2024 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 5,000 | $10.49 | $52,432.50 | +6.2% | -22.5% | +107.3% | |
| Jan 16, 2024 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 2,000 | $14.50 | $29,000.00 | +2.5% | +14.2% | -45.2% | |
| Aug 14, 2023 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 2,000 | $14.45 | $28,900.00 | +2.6% | -23.0% | +16.4% | |
| Nov 29, 2022 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 5,000 | $7.80 | $39,000.00 | +7.0% | +24.6% | +45.5% | |
| May 27, 2022 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 50,000 | $2.14 | $106,895.00 | +232.6% | +182.0% | +453.6% | |
| Sep 18, 2020 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 4,000 | $6.00 | $24,000.00 | +22.9% | - | - | |
| Aug 28, 2020 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 7,500 | $6.77 | $50,776.50 | +75.0% | - | - | |
| Aug 13, 2020 | AVDL Avadel Pharmaceuticals Plc | Chief Financial Officer | Buy | 10,000 | $7.78 | $77,814.00 | New | - | - |